...
search icon
abeo-img

Abeona Therapeutics Inc, Common Stock

ABEO

NAQ

$5.43

-$0.2

(-3.55%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$280.84M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
900.43K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.68
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.93 L
$7.32 H
$5.43

About Abeona Therapeutics Inc, Common Stock

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameABEOSectorS&P500
1-Week Return-2.17%-1.83%5.04%
1-Month Return13.74%-4.81%8.87%
3-Month Return-5.06%-9.92%-3.79%
6-Month Return-7.7%-10.19%-1.75%
1-Year Return30.93%-8.07%12.67%
3-Year Return39.1%2.54%46.13%
5-Year Return-93.11%33.88%108.49%
10-Year Return-97.38%80.4%180.2%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue10.00M3.00M1.41M3.50M-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":30,"profit":true},{"date":"2022-12-31","value":14.14,"profit":true},{"date":"2023-12-31","value":35,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue30.14M4.46M450.00K1.60M-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":14.81,"profit":true},{"date":"2022-12-31","value":1.49,"profit":true},{"date":"2023-12-31","value":5.33,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(20.14M)(1.46M)964.00K1.90M-[{"date":"2020-12-31","value":-1062.74,"profit":false},{"date":"2021-12-31","value":-77.26,"profit":false},{"date":"2022-12-31","value":50.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin(201.39%)(48.80%)68.18%54.14%-[{"date":"2020-12-31","value":-295.4,"profit":false},{"date":"2021-12-31","value":-71.58,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.42,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses58.50M60.37M46.22M49.03M64.21M[{"date":"2020-12-31","value":91.11,"profit":true},{"date":"2021-12-31","value":94.02,"profit":true},{"date":"2022-12-31","value":71.98,"profit":true},{"date":"2023-12-31","value":76.36,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(81.42M)(89.84M)(45.26M)(47.13M)(64.21M)[{"date":"2020-12-31","value":-8142000000,"profit":false},{"date":"2021-12-31","value":-8983600000,"profit":false},{"date":"2022-12-31","value":-4525700000,"profit":false},{"date":"2023-12-31","value":-4713500000,"profit":false},{"date":"2024-12-31","value":-6421100000,"profit":false}]
Total Non-Operating Income/Expense(5.63M)1.30M10.91M(5.35M)515.00K[{"date":"2020-12-31","value":-51.57,"profit":false},{"date":"2021-12-31","value":11.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-49.06,"profit":false},{"date":"2024-12-31","value":4.72,"profit":true}]
Pre-Tax Income(84.23M)(84.94M)(39.70M)(54.19M)(63.73M)[{"date":"2020-12-31","value":-8423400000,"profit":false},{"date":"2021-12-31","value":-8493600000,"profit":false},{"date":"2022-12-31","value":-3969600000,"profit":false},{"date":"2023-12-31","value":-5418800000,"profit":false},{"date":"2024-12-31","value":-6373400000,"profit":false}]
Income Taxes4.12M3.67M(7.89M)3.03M-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.19,"profit":true},{"date":"2022-12-31","value":-191.66,"profit":false},{"date":"2023-12-31","value":73.64,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(88.35M)(88.61M)(31.81M)(57.22M)-[{"date":"2020-12-31","value":-8834900000,"profit":false},{"date":"2021-12-31","value":-8860600000,"profit":false},{"date":"2022-12-31","value":-3180900000,"profit":false},{"date":"2023-12-31","value":-5721810500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(84.23M)(84.94M)(39.70M)(54.19M)(63.73M)[{"date":"2020-12-31","value":-8423400000,"profit":false},{"date":"2021-12-31","value":-8493600000,"profit":false},{"date":"2022-12-31","value":-3969600000,"profit":false},{"date":"2023-12-31","value":-5418800000,"profit":false},{"date":"2024-12-31","value":-6373400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(88.35M)(88.61M)(31.81M)(54.19M)(63.73M)[{"date":"2020-12-31","value":-8834900000,"profit":false},{"date":"2021-12-31","value":-8860600000,"profit":false},{"date":"2022-12-31","value":-3180900000,"profit":false},{"date":"2023-12-31","value":-5418800000,"profit":false},{"date":"2024-12-31","value":-6373400000,"profit":false}]
EPS (Diluted)(13.75)(15.75)(5.53)(2.71)(1.60)[{"date":"2020-12-31","value":-1375,"profit":false},{"date":"2021-12-31","value":-1575,"profit":false},{"date":"2022-12-31","value":-553,"profit":false},{"date":"2023-12-31","value":-271,"profit":false},{"date":"2024-12-31","value":-160.02,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ABEO
Cash Ratio 5.89
Current Ratio 6.08

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ABEO
ROA (LTM) -46.41%
ROE (LTM) -216.57%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ABEO
Debt Ratio Lower is generally better. Negative is bad. 0.60
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.40

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ABEO
Trailing PE NM
Forward PE NM
P/S (TTM) 37.76
P/B 6.24
Price/FCF NM
EV/R 53.29
EV/Ebitda NM
PEG NM

FAQs

What is Abeona Therapeutics Inc share price today?

Abeona Therapeutics Inc (ABEO) share price today is $5.43

Can Indians buy Abeona Therapeutics Inc shares?

Yes, Indians can buy shares of Abeona Therapeutics Inc (ABEO) on Vested. To buy Abeona Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABEO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Abeona Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Abeona Therapeutics Inc (ABEO) via the Vested app. You can start investing in Abeona Therapeutics Inc (ABEO) with a minimum investment of $1.

How to invest in Abeona Therapeutics Inc shares from India?

You can invest in shares of Abeona Therapeutics Inc (ABEO) via Vested in three simple steps:

  • Click on Sign Up or Invest in ABEO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Abeona Therapeutics Inc shares
What is Abeona Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Abeona Therapeutics Inc (ABEO) is $7.32. The 52-week low price of Abeona Therapeutics Inc (ABEO) is $3.93.

What is Abeona Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Abeona Therapeutics Inc (ABEO) is 6.24

What is the Market Cap of Abeona Therapeutics Inc?

The market capitalization of Abeona Therapeutics Inc (ABEO) is $280.84M

What is Abeona Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Abeona Therapeutics Inc is ABEO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top